![Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial - The Lancet Respiratory Medicine Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/f516168b-ca27-473e-b972-7e038d69ea88/gr1.gif)
Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial - The Lancet Respiratory Medicine
![Clinical and Safety Outcomes of Long-Term Azithromycin Therapy in Severe COPD Beyond the First Year of Treatment - ScienceDirect Clinical and Safety Outcomes of Long-Term Azithromycin Therapy in Severe COPD Beyond the First Year of Treatment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0012369218302459-gr1.jpg)
Clinical and Safety Outcomes of Long-Term Azithromycin Therapy in Severe COPD Beyond the First Year of Treatment - ScienceDirect
![PDF] The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial | Semantic Scholar PDF] The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4de5cae4249199ae0afeafee4a7cef12f2198061/3-Table1-1.png)
PDF] The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial | Semantic Scholar
Change of microbiology by AECOPD severity during long-term azithromycin... | Download Scientific Diagram
![Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial - The Lancet Respiratory Medicine Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/fb41bb23-24c6-495a-bcf5-3907ffff765a/gr1_lrg.gif)
Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial - The Lancet Respiratory Medicine
![Long-term daily high and low doses of azithromycin in children with cystic fibrosis: A randomized controlled trial - ScienceDirect Long-term daily high and low doses of azithromycin in children with cystic fibrosis: A randomized controlled trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1569199309001234-gr1.jpg)
Long-term daily high and low doses of azithromycin in children with cystic fibrosis: A randomized controlled trial - ScienceDirect
Should azithromycin be used to treat COVID-19? — Nuffield Department of Primary Care Health Sciences, University of Oxford
![Frontiers | Systemic and functional effects of continuous azithromycin treatment in patients with severe chronic obstructive pulmonary disease and frequent exacerbations Frontiers | Systemic and functional effects of continuous azithromycin treatment in patients with severe chronic obstructive pulmonary disease and frequent exacerbations](https://www.frontiersin.org/files/Articles/1229463/fmed-10-1229463-HTML-r2/image_m/fmed-10-1229463-g001.jpg)
Frontiers | Systemic and functional effects of continuous azithromycin treatment in patients with severe chronic obstructive pulmonary disease and frequent exacerbations
![The impact of long-term azithromycin on antibiotic resistance in HIV-associated chronic lung disease | European Respiratory Society The impact of long-term azithromycin on antibiotic resistance in HIV-associated chronic lung disease | European Respiratory Society](https://openres.ersjournals.com/content/erjor/8/1/00491-2021/F1.large.jpg)